[Pseudoparalysis induced by cancer chemotherapy (cis-platinum)]. 1985

B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg

UI MeSH Term Description Entries
D006996 Hypocalcemia Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed) Hypocalcemias
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D009123 Muscle Hypotonia A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching. Flaccid Muscle Tone,Hypotonia,Decreased Muscle Tone,Floppy Muscles,Hypomyotonia,Hypotony, Muscle,Muscle Flaccidity,Muscle Tone Atonic,Muscle Tone Poor,Muscular Flaccidity,Muscular Hypotonia,Neonatal Hypotonia,Unilateral Hypotonia,Flaccidity, Muscle,Flaccidity, Muscular,Floppy Muscle,Hypotonia, Muscle,Hypotonia, Muscular,Hypotonia, Neonatal,Hypotonia, Unilateral,Hypotonias, Neonatal,Hypotonias, Unilateral,Muscle Hypotony,Muscle Tone Atonics,Muscle Tone, Decreased,Muscle Tone, Flaccid,Muscle, Floppy,Muscles, Floppy,Muscular Flaccidities,Neonatal Hypotonias,Tone Atonic, Muscle,Tone Poor, Muscle
D010243 Paralysis A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45) Palsy,Plegia,Todd Paralysis,Todd's Paralysis,Palsies,Paralyses,Paralysis, Todd,Paralysis, Todd's,Plegias,Todds Paralysis
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014883 Water-Electrolyte Imbalance Disturbances in the body's WATER-ELECTROLYTE BALANCE. Imbalance, Water-Electrolyte,Imbalances, Water-Electrolyte,Water Electrolyte Imbalance,Water-Electrolyte Imbalances

Related Publications

B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
January 1982, Cancer chemotherapy and pharmacology,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
January 1986, Harefuah,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
April 1982, Mutation research,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
November 1982, Journal of the Iowa Medical Society,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
January 1979, Cancer clinical trials,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
July 1979, The New England journal of medicine,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
July 1986, Scandinavian journal of haematology,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
March 1984, Gynecologic oncology,
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
November 1983, Presse medicale (Paris, France : 1983),
B Leclercq, and B Escudier, and F Tandonnet, and G Conscience, and E Roussignol, and G Nitenberg
September 1985, Gan no rinsho. Japan journal of cancer clinics,
Copied contents to your clipboard!